Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KROS)

CUSIP: 492327101

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
-15,029,816
Put/Call ratio
44%
SEC-reported price per share
$20.36
Number of holders
162
Value change
-$274,897,076
Number of buys
77
Show 1 more signal
Number of sells
98
Security identity Who this page is about. 1 source field
Shares outstanding
19,716,217

Security key

492327101

Report period

Q4 2025

Institutions

162

Top holders

10

Ownership snapshot

Top reported holders of KROS - Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
D. E. SHAW & CO, L.P.
Disclosed value leader
ADAR1 Capital Management,...
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G 13F 3/4/5 Lead comparable stake: 3.9% 13D/G row: D. E. SHAW & CO, L.P. Showing 1-6 of 15 holder rows.

Quick read

D. E. SHAW & CO, L.P. leads the comparable SEC ownership view at 3.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens D. E. SHAW & CO, L.P.'s linked filing trail.
Comparable ownership Top 5
D. E. SHAW & CO, L.P. 3.9%
Madison Avenue Partners, LP 2.7%
ALKEON CAPITAL MANAGEMENT LLC 2.7%
FMR LLC 1.7%
JPMORGAN CHASE & CO 0.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
D. E. SHAW & CO, L.P.
13D/G
3.9%
$14,745,042
756,156 shares
-$15,400,944 31 Dec 2025
Madison Avenue Partners, LP
13F 13D/G
Company · Madison Avenue International LP
2.7%
from 13D/G
$42,844,009
2,708,218 shares
30 Sep 2025
ALKEON CAPITAL MANAGEMENT LLC
13D/G 13F
Company
2.7%
$15,645,210
1,101,000 shares
$0 31 Dec 2024
FMR LLC
13D/G 13F
Company
1.7%
$10,010,547
704,472 shares
$0 31 Jan 2025
JPMORGAN CHASE & CO
13F 13D/G
Company
0.2%
from 13D/G
$2,720,107
171,941 shares
30 Sep 2025
ExodusPoint Capital Management, LP
13D/G
0.04%
$260,520
13,360 shares
-$36,943,510 31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
162
Shares
20,068,551
Rows available
162
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
151
Q4 2025 holders
162
Holder diff
11
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .